| Basic Medical Information |
| Common Brand Name |
| Altace |
Vasotec |
| Drug Class |
| Ace Inhibitors |
Ace Inhibitors |
| Legal Status |
| Pom (uk), Rx-only (us) |
Rx -only |
| Possible Side Effects |
| Low Blood Sugar, Dry Cough, Dizziness, Tiredness, Mouth Dryness, Nausea, Vomiting, Diarrhea, Fainting, Change In Amount Of Urine, Yellowing Of Eyes Or Skin, Dark Urine, Abdominal Pain, Neutropenia, Impotence |
Cough, Dizziness, Skin Rashes, Weakness, Hoarseness, Difficulty Breathing Or Swallowing, Yellowing Of The Skin, Yellowing Of The Eyes, Fever, Sore Throat, Chills, Yellowing, Lightheadedness, Fainting |
| Precautions & Contraindications |
| Angina, Atherosclerosis, Mitral Insufficiency, Renovascular Hypertension, Diabetic Or Nondiabetic Nephropathy, Erythrocytosis |
Hypertrophic Cardiomyopathy, Impaired Renal Function, Hyperkalemia, Surgery, Carcinogenesis, Pregnant |
| Excretion |
| Renal, Fecal |
Renal |
|
| Dosage, Usage and Forms |
| Route of Administration |
| Oral |
Oral, Iv |
| Dosage |
| 2.5 Mg |
5 Mg |
| Maximum daily dose |
| 20 mg |
40 mg |
| Forms |
| Capsule |
Tablet, Iv |
| Tablet Formulations |
|
2.5 Mg, 5 Mg, 10 Mg, 20 Mg |
| Capsule Formulations |
| 1.25 Mg, 2.5 Mg, 5 Mg, 10 Mg |
|
| IV Solution Formulations |
|
1.25 Mg/ml |
| Chemical Data |
| Molecular mass (g/mol) |
| 416.51 g/mol |
376.45 g/mol |
| Half Life (hours) |
| 4 |
11 |
| Chemicals |
| Carbon, Hydrogen, Nitrogen, Oxygen |
Carbon, Hydrogen, Nitrogen, Oxygen |
| Formula |
| C23h32n2o5 |
C20h28n2o5 |
| Melting Point (C) |
| 109 C |
144.5 C |
| Phase (solid/liquid) |
| Solid |
Solid, Liquid |